|
P450 (CYP) pathways |
|
Pain control |
|
|
|
Paliperidone dose and administration information |
|
|
|
Pancreatitis |
|
|
|
|
|
Paradoxical disinhibition/aggressive drug reactions, benzodiazepines |
|
Parenteral treatment, for acutely disturbed/violent patients |
|
Parotid gland swelling |
|
Pathological laughter (pseudobulbar affect), multiple sclerosis |
|
|
|
People living with human immunodeficiency virus |
|
|
|
People with epilepsy, risks |
|
|
|
|
|
|
|
|
|
|
|
Perimenopause |
|
perioperative blood loss, SSRI risks |
|
Personal and cultural beliefs, influencing adherence |
|
|
|
|
|
Pharmacodynamic interactions with alcohol |
|
|
|
Pharmacokinetic drug interactions |
|
|
